TRK-IN-28
Product Specifications
UNSPSC Description
TRK-IN-28 (compound 30f) is a TRK inhibitor with the IC50 values of 0.55 nM, 25.1 nM and 5.4 nM against TRKWT, TRKG595R and TRKG667C, respectively. TRK-IN-2 shows antiproliferative activity with IC50 values of 9.5, 3.7, 205.0 and 48.3 nM against Ba/F3-ETV6-TRKAWT, Ba/F3-ETV6-TRKBWT, Ba/F3-LMNA-TRKG595R and Ba/F3-LMNA-TRKAG667C, respectively[1].
Target Antigen
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trk-in-28.html
Solubility
10 mM in DMSO
Smiles
FC1=CC(CC2=CC3=C(NN=C3NC4=C5C=CC(N6CCN(CC6)C)=CC5=NC=N4)C=C2)=CC(F)=C1
Molecular Weight
485.53
References & Citations
[1]Xu Y, et al. Design, synthesis and evaluate of indazolylaminoquinazoline derivatives as potent Tropomyosin receptor kinase (TRK) inhibitors. Bioorg Med Chem. 2024;99:117608.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
CAS Number
2991504-43-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1354003-01 0.02 mg (E-Coli)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1354003-02 0.02 mg (Yeast)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1354003-03 0.1 mg (E-Coli)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details 
MBS1354003-04 0.1 mg (Yeast)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1354003-05 0.02 mg (Baculovirus)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details MBS1354003-06 0.02 mg (Mammalian-Cell)
Recombinant Haemophilus ducreyi D-alanine--D-alanine ligase (ddl)
Ask
View Details